title: [Recommended treatment of apnea in premature infants. A review based on literature and own experience].
abstract: The authors reviewed the literature concerning different methods of treatment of apnea in premature infants. The authors consider that, apart from pharmacological treatment, noninvasive respiratory support methods play an important role in the prevention and treatment of newborns with apnea. The aim of the study is to present current recommendations concerning the principles of prevention and treatment of apnea in premature infants. The compiled recommendations are based on the data from literature and from the authors' own experiences.
authors.affiliation: Klinika Intensywnej Terapii i Patologii Noworodka, Górnoślaskie Centrum Zdrowia Dziecka, Slaski Uniwersytet Medyczny, 40-752 Katowice. bober_k@interia.pl
authors.forename: Klaudiusz
authors.initials: K
authors.lastname: Bober
authors.forename: Janusz
authors.initials: J
authors.lastname: Swietliński
authors.forename: Ewa
authors.initials: E
authors.lastname: Musialik-Swietlińska
authors.forename: Maria Katarzyna
authors.initials: MK
authors.lastname: Kornacka
authors.forename: Magdalena
authors.initials: M
authors.lastname: Rutkowska
authors.forename: Marcin
authors.initials: M
authors.lastname: Rawicz
mesh_terms: D001049:Apnea / Q000628:therapy*; D015975:Consensus Development Conferences, NIH as Topic; D045422:Continuous Positive Airway Pressure; D003422:Critical Care / Q000379:methods; D004315:Doxapram / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000628:therapy*; D011044:Poland; D019141:Respiratory System Agents / Q000627:therapeutic use; D014481:United States; D014970:Xanthines / Q000627:therapeutic use
chemical_list: D019141:Respiratory System Agents; D014970:Xanthines; C053085:1-methylxanthine; D004315:Doxapram